Vaccination with Recombinant Cryptococcus Proteins in Glucan Particles Protects Mice against Cryptococcosis in a Manner Dependent upon Mouse Strain and …
CA Specht, CK Lee, H Huang, MM Hester, J Liu… - MBio, 2017 - Am Soc Microbiol
Development of a vaccine to protect against cryptococcosis is a priority given the enormous
global burden of disease in at-risk individuals. Using glucan particles (GPs) as a delivery …
global burden of disease in at-risk individuals. Using glucan particles (GPs) as a delivery …
Vaccination with Recombinant Cryptococcus Proteins in Glucan Particles Protects Mice against Cryptococcosis in a Manner Dependent upon Mouse Strain and …
CA Specht, CK Lee, H Huang, MM Hester, J Liu… - 2017 - agris.fao.org
Development of a vaccine to protect against cryptococcosis is a priority given the enormous
global burden of disease in at-risk individuals. Using glucan particles (GPs) as a delivery …
global burden of disease in at-risk individuals. Using glucan particles (GPs) as a delivery …
[HTML][HTML] Vaccination with Recombinant Cryptococcus Proteins in Glucan Particles Protects Mice against Cryptococcosis in a Manner Dependent upon Mouse Strain …
CA Specht, CK Lee, H Huang, MM Hester, J Liu… - mBio, 2017 - ncbi.nlm.nih.gov
Development of a vaccine to protect against cryptococcosis is a priority given the enormous
global burden of disease in at-risk individuals. Using glucan particles (GPs) as a delivery …
global burden of disease in at-risk individuals. Using glucan particles (GPs) as a delivery …
Vaccination with Recombinant Cryptococcus Proteins in Glucan Particles Protects Mice against Cryptococcosis in a Manner Dependent upon Mouse Strain and …
CA Specht, CK Lee, H Huang, MM Hester, J Liu… - Mbio, 2017 - europepmc.org
Development of a vaccine to protect against cryptococcosis is a priority given the enormous
global burden of disease in at-risk individuals. Using glucan particles (GPs) as a delivery …
global burden of disease in at-risk individuals. Using glucan particles (GPs) as a delivery …
Vaccination with Recombinant Cryptococcus Proteins in Glucan Particles Protects Mice against Cryptococcosis in a Manner Dependent upon Mouse Strain and …
CA Specht, CK Lee, H Huang, MM Hester, J Liu… - 2017 - repository.escholarship.umassmed …
Development of a vaccine to protect against cryptococcosis is a priority given the enormous
global burden of disease in at-risk individuals. Using glucan particles (GPs) as a delivery …
global burden of disease in at-risk individuals. Using glucan particles (GPs) as a delivery …
Vaccination with recombinant Cryptococcus proteins in glucan particles protects mice against cryptococcosis in a manner dependent upon mouse strain and …
CA Specht, CK Lee, HHB Huang HaiBin, MM Hester… - 2017 - cabidigitallibrary.org
Abstract Development of a vaccine to protect against cryptococcosis is a priority given the
enormous global burden of disease in at-risk individuals. Using glucan particles (GPs) as a …
enormous global burden of disease in at-risk individuals. Using glucan particles (GPs) as a …
Vaccination with recombinant Cryptococcus proteins in glucan particles protects mice against cryptococcosis in a manner dependent upon mouse strain and …
CA Specht, CK Lee, H Huang, MM Hester, J Liu… - mBio, 2017 - profiles.wustl.edu
Abstract Development of a vaccine to protect against cryptococcosis is a priority given the
enormous global burden of disease in at-risk individuals. Using glucan particles (GPs) as a …
enormous global burden of disease in at-risk individuals. Using glucan particles (GPs) as a …
Vaccination with Recombinant Cryptococcus Proteins in Glucan Particles Protects Mice against Cryptococcosis in a Manner Dependent upon Mouse Strain and …
CA Specht, CK Lee, H Huang, MM Hester, J Liu… - mBio, 2017 - pubmed.ncbi.nlm.nih.gov
Development of a vaccine to protect against cryptococcosis is a priority given the enormous
global burden of disease in at-risk individuals. Using glucan particles (GPs) as a delivery …
global burden of disease in at-risk individuals. Using glucan particles (GPs) as a delivery …
Vaccination with Recombinant Cryptococcus Proteins in Glucan Particles Protects Mice against Cryptococcosis in a Manner Dependent upon Mouse …
CA Specht, CK Lee, H Huang, MM Hester, J Liu… - mBio, 2017 - cir.nii.ac.jp
抄録< jats: title> ABSTRACT</jats: title>< jats: p> Development of a vaccine to protect
against cryptococcosis is a priority given the enormous global burden of disease in at-risk …
against cryptococcosis is a priority given the enormous global burden of disease in at-risk …